Ajanta Pharma Ltd Annually Results

Gross Sales

4,648.1

4,208.71

3,742.64

3,340.99

2,889.69

Excise Duty

0

0

0

0

0

Net Sales

4,648.1

4,208.71

3,742.64

3,340.99

2,889.69

Other Operating Income

0

0

0

0

0

Other Income

94.5

84.6

98.64

115.68

25.98

Total Income

4,742.6

4,293.31

3,841.28

3,456.67

2,915.67

Total Expenditure

3,388.6

3,036.77

2,959.39

2,411.69

1,891.13

PBIDT

1,354

1,256.54

881.89

1,044.98

1,024.54

Interest

20.73

7.21

5.84

10.2

8.27

PBDT

1,333.27

1,249.33

876.05

1,034.78

1,016.27

Depreciation

144.11

135.4

130.8

125.3

116.09

Minority Interest Before NP

0

0

0

0

0

Tax

312.3

322.06

197.24

191.67

261.36

Deferred Tax

-43.53

-24.3

-39.97

5.13

-15.05

Reported Profit After Tax

920.39

816.17

587.98

712.68

653.87

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

920.39

816.17

587.98

712.68

653.87

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

920.39

816.17

587.98

712.68

653.87

EPS (Unit Curr.)

73.56

64.82

49.89

54.97

75.09

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,400

2,550

350

475

475

Equity

25.27

25.27

25.27

17.17

17.39

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

29.13

29.85

23.56

31.27

35.45

PBDTM(%)

28.68

29.68

23.4

30.97

35.16

PATM(%)

19.8

19.39

15.71

21.33

22.62